Literature DB >> 28361075

Liposteroid therapy for juvenile and adult dermatomyositis: efficacy and side effects.

Hiroyuki Wakiguchi1.   

Abstract

Entities:  

Year:  2017        PMID： 28361075      PMCID： PMC5360609          DOI： 10.21037/atm.2017.01.36

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  Severe gluteal skin ulcers in an infant with juvenile dermatomyositis.

Authors:  Hiroyuki Wakiguchi; Syuji Takei; Hiroyuki Imanaka; Tsubasa Hiraki; Michiyo Higashi; Tsuyoshi Yamatou; Yuichi Yamasaki; Tomohiro Kubota; Yoshifumi Kawano
Journal:  Eur J Dermatol       Date:  2016-04-01       Impact factor: 3.328

2.  Role of activated macrophage and inflammatory cytokines in the development of calcinosis in juvenile dermatomyositis.

Authors:  Masaki Shimizu; Kazuyuki Ueno; Sayaka Ishikawa; Yoshihito Kasahara; Akihiro Yachie
Journal:  Rheumatology (Oxford)       Date:  2013-11-04       Impact factor: 7.580

3.  Axillary Skin Ulcers in Infants with Juvenile Dermatomyositis.

Authors:  Hiroyuki Wakiguchi; Syuji Takei; Yoshifumi Kawano
Journal:  Pediatr Neonatol       Date:  2016-09-20       Impact factor: 2.083

Review 4.  Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation.

Authors:  Hiroyuki Wakiguchi; Shouichi Ohga
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2016

5.  Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy.

Authors:  Satoshi Nishiwaki; Takayuki Nakayama; Makoto Murata; Tetsuya Nishida; Kyoko Sugimoto; Shigeki Saito; Tomonori Kato; Hiroki Mizuno; Nobuhiko Imahashi; Aika Seto; Yukiyasu Ozawa; Tatsunori Goto; Daisuke Koyama; Emi Yokohata; Naomi Kubota; Sonoko Kamoshita; Koichi Miyamura; Kimikazu Matsumoto; Masafumi Ito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2012-02-15       Impact factor: 2.490

6.  MHC Class I overexpression on muscles in early juvenile dermatomyositis.

Authors:  Charles K C Li; Hemlata Varsani; Janice L Holton; Bin Gao; Patricia Woo; Lucy R Wedderburn
Journal:  J Rheumatol       Date:  2004-03       Impact factor: 4.666

Review 7.  Bioactive lipid mediators in skin inflammation and immunity.

Authors:  Alexandra C Kendall; Anna Nicolaou
Journal:  Prog Lipid Res       Date:  2012-11-01       Impact factor: 16.195

8.  Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.

Authors:  Y Mizushima; T Hamano; K Yokoyama
Journal:  Ann Rheum Dis       Date:  1982-06       Impact factor: 19.103

9.  Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels.

Authors:  Hiroyuki Wakiguchi; Shunji Hasegawa; Reiji Hirano; Hidenobu Kaneyasu; Midori Wakabayashi-Takahara; Shouichi Ohga
Journal:  Pediatr Rheumatol Online J       Date:  2015-11-18       Impact factor: 3.054

10.  Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions.

Authors:  Satoshi Nishiwaki; Takayuki Nakayama; Makoto Murata; Tetsuya Nishida; Seitaro Terakura; Shigeki Saito; Tomonori Kato; Hiroki Mizuno; Nobuhiko Imahashi; Aika Seto; Yukiyasu Ozawa; Koichi Miyamura; Masafumi Ito; Kyosuke Takeshita; Hidefumi Kato; Shinya Toyokuni; Keisuke Nagao; Ryuzo Ueda; Tomoki Naoe
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.